Memantine LEK
Kraj: Unia Europejska
Język: łotewski
Źródło: EMA (European Medicines Agency)
Ulotka dla pacjenta
(PIL)
16-11-2020
Charakterystyka produktu
(SPC)
16-11-2020
Sprawozdanie z oceny publicznego
(PAR)
29-04-2013
Składnik aktywny:
memantīna hidrohlorīds
Dostępny od:
Pharmathen S.A.
Kod ATC:
N06DX01
INN (International Nazwa):
memantine
Grupa terapeutyczna:
Psychoanaleptics, , Citas anti-demenci zāles
Dziedzina terapeutyczna:
Alcheimera slimība
Wskazania:
Pacientiem ar vidēji smagu vai smagu Alcheimera slimību ārstēšana.
Podsumowanie produktu:
Revision: 5
Status autoryzacji:
Autorizēts
Data autoryzacji:
2013-04-21
Ulotka dla pacjenta
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Przeczytaj cały dokument
Charakterystyka produktu
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
Przeczytaj cały dokument
